- A novel class of self-complementary AAV vectors with multiple advantages based on cceAAV lacking mutant ITR.Molecular Therapy: Methods & Clinical Development,2024,
- Quantitative analysis of preferential utilization of AAV ITR as the packaging terminal signal.Frontiers in bioengineering and biotechnology,2023,
- Subgenomic particles in rAAV vectors result from DNA lesion/break and non-homologous end joining of vector genomes.Molecular Therapy Nucleic Acid,2022,
- "D" matters in recombinant AAV DNA packaging.Molecular Therapy,2021,
- Flies in the ointment: AAV vector preparations and tumor risk.Molecular Therapy,2021,
